Capital Fund Management (CFM)
BMY icon

Capital Fund Management (CFM)’s Bristol-Myers Squibb BMY Stock Holding History

Capital Fund Management (CFM)’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.5M Sell
271,500
-189,500
-41% -$11M 0.07% 370
2025
Q4 		$24.9M Sell
461,000
-796,700
-63% -$38.3M 0.07% 398
2025
Q3 		$56.7M Sell
1,257,700
-116,000
-8% -$5.42M 0.15% 159
2025
Q2 		$63.6M Sell
1,373,700
-422,200
-24% -$20.7M 0.18% 157
2025
Q1 		$110M Buy
1,795,900
+1,800
+0.1% +$105K 0.32% 51
2024
Q4 		$101M Sell
1,794,100
-528,100
-23% -$29.5M 0.26% 86
2024
Q3 		$120M Buy
2,322,200
+99,500
+4% +$4.67M 0.33% 65
2024
Q2 		$92.3M Buy
2,222,700
+163,400
+8% +$7.31M 0.27% 86
2024
Q1 		$112M Sell
2,059,300
-892,500
-30% -$45.5M 0.32% 49
2023
Q4 		$151M Buy
2,951,800
+1,240,400
+72% +$65.1M 0.41% 31
2023
Q3 		$99.3M Buy
1,711,400
+458,400
+37% +$28.1M 0.34% 56
2023
Q2 		$80.1M Buy
1,253,000
+610,500
+95% +$40.9M 0.32% 56
2023
Q1 		$44.5M Buy
642,500
+84,200
+15% +$5.94M 0.21% 118
2022
Q4 		$40.2M Buy
558,300
+120,500
+28% +$9.09M 0.27% 85
2022
Q3 		$31.1M Sell
437,800
-12,200
-3% -$885K 0.24% 99
2022
Q2 		$34.6M Buy
450,000
+185,700
+70% +$14.1M 0.32% 56
2022
Q1 		$19.3M Buy
264,300
+53,200
+25% +$3.57M 0.16% 176
2021
Q4 		$13.2M Sell
211,100
-19,500
-8% -$1.14M 0.09% 290
2021
Q3 		$13.6M Buy
+230,600
New +$15.2M 0.1% 273
2021
Q2 		– Sell
-86,600
Closed -$5.47M – 1435
2021
Q1 		$5.47M Buy
86,600
+51,400
+146% +$3.2M 0.06% 388
2020
Q4 		$2.18M Sell
35,200
-444,000
-93% -$27.3M 0.02% 753
2020
Q3 		$28.9M Buy
479,200
+156,900
+49% +$9.44M 0.36% 67
2020
Q2 		$19M Sell
322,300
-696,500
-68% -$41.7M 0.3% 91
2020
Q1 		$56.8M Buy
1,018,800
+469,500
+85% +$28.7M 0.88% 8
2019
Q4 		$35.3M Buy
549,300
+429,300
+358% +$24.6M 0.28% 87
2019
Q3 		$6.08M Buy
120,000
+26,700
+29% +$1.25M 0.05% 420
2019
Q2 		$4.23M Buy
93,300
+9,200
+11% +$429K 0.04% 561
2019
Q1 		$4.01M Sell
84,100
-408,000
-83% -$20.3M 0.04% 570
2018
Q4 		$25.6M Sell
492,100
-243,000
-33% -$13.1M 0.23% 105
2018
Q3 		$45.6M Sell
735,100
-793,100
-52% -$47.1M 0.25% 81
2018
Q2 		$84.6M Buy
1,528,200
+1,452,500
+1,919% +$78.4M 0.44% 21
2018
Q1 		$4.79M Sell
75,700
-40,400
-35% -$2.6M 0.03% 703
2017
Q4 		$7.12M Sell
116,100
-13,600
-10% -$851K 0.04% 521
2017
Q3 		$8.27M Sell
129,700
-26,400
-17% -$1.54M 0.06% 389
2017
Q2 		$8.7M Sell
156,100
-513,900
-77% -$28M 0.07% 323
2017
Q1 		$36.4M Sell
670,000
-359,100
-35% -$19.7M 0.3% 81
2016
Q4 		$60.1M Buy
1,029,100
+146,900
+17% +$8.03M 0.52% 24
2016
Q3 		$47.6M Buy
882,200
+804,800
+1,040% +$51.7M 0.44% 53
2016
Q2 		$5.69M Buy
77,400
+18,600
+32% +$1.31M 0.05% 394
2016
Q1 		$3.76M Sell
58,800
-95,700
-62% -$6.04M 0.04% 522
2015
Q4 		$10.6M Buy
154,500
+13,300
+9% +$879K 0.11% 251
2015
Q3 		$8.36M Sell
141,200
-347,500
-71% -$22M 0.09% 273
2015
Q2 		$32.5M Buy
488,700
+106,500
+28% +$7.02M 0.41% 45
2015
Q1 		$24.7M Buy
382,200
+246,900
+182% +$15.5M 0.34% 69
2014
Q4 		$7.99M Buy
135,300
+45,600
+51% +$2.57M 0.09% 289
2014
Q3 		$4.59M Sell
89,700
-647,600
-88% -$32.3M 0.05% 438
2014
Q2 		$35.8M Buy
737,300
+309,900
+73% +$15.3M 0.38% 43
2014
Q1 		$22.2M Buy
427,400
+254,300
+147% +$13.5M 0.27% 69
2013
Q4 		$9.2M Sell
173,100
-20,000
-10% -$1.02M 0.11% 216
2013
Q3 		$8.94M Sell
193,100
-124,000
-39% -$5.44M 0.12% 215
2013
Q2 		$14.2M Buy
+317,100
New +$13.8M 0.22% 87

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Fund Management (CFM)'s BMY Position: Q1 2026 in Review

Capital Fund Management (CFM) reduced its Bristol-Myers Squibb (BMY) stake by 78% in Q1 2026, selling an estimated $49.2M and leaving 236,442 shares worth $14.3M. The position accounts for 0.06% of the portfolio, ranked #421.

Capital Fund Management (CFM) first reported a position in BMY in Q1 2014 and has held it in 34 quarters since. The position peaked at $98.8M in Q2 2018. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Capital Fund Management (CFM) held 236,442 shares of Bristol-Myers Squibb worth $14.3M as of Q1 2026.
  • Capital Fund Management (CFM) sold 844,824 Bristol-Myers Squibb shares in Q1 2026, an estimated $49.2M.
  • Bristol-Myers Squibb made up 0.06% of Capital Fund Management (CFM)'s portfolio in Q1 2026, its #421 holding.
  • Capital Fund Management (CFM) first reported a position in Bristol-Myers Squibb in Q1 2014 and has held it in 34 quarters since.
  • Capital Fund Management (CFM)'s Bristol-Myers Squibb position peaked at $98.8M in Q2 2018.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q1 2026, filed 14 May 2026.